Nanoflex Robotics awarded €12.5 million EIC blended financing
Nanoflex Robotics was selected for €12.5 million of EIC Accelerator financing to complete clinical validation and prepare its first commercial system.
Evidence notes
- The package comprises a €2.5 million grant and €10 million equity investment from the EIC Fund.
- Funding supports clinical validation and work toward CE marking in Europe.
- Nanoflex was the only medical-technology company among the selected Swiss applicants.